P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial

ABSTRACT:

SUBMITTER: Brockelmann P 

PROVIDER: S-EPMC9621519 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature